In contrast t o C5a. which represents a well-established potent activator of the respiratory burst in polymorphonuclear neutrophilic granulocytes (PMN), the functional role of C3a in the activation of PMN is, so far, poorly understood. Herein, the potential role of human C3a in the activation of the respiratory burst in human PMN was investigated. The release of reactive oxygen species (ROS) of PMN from healthy donors was measured by lucigenin-dependent chemiluminescence. C3a dose-dependently induced the production of ROS in human PMN in the range between 10 ng/mL and 1,000 ng/mL, whereas C3a-desArg was inactive. Flow cytometric measurement of HaOp by dihydrorhodamine-123 labeling of anti-CD16-stained PMN showed that predominantly neutrophilic PMN are responsible for the C3a-induced activation of the respiratory burst. To exclude that C3a stimulation was caused by contamination with C5a. the specificity of C3a-induced activation of PMN was shown using monoclonal antibodies (MoAbs). Accordingly, the effect of C3a was completely abolished in the presence of Fab fragments of a blocking anti-C3a MoAb. In addition, blockade of the C5a receptor by the anti-C5a receptor (anti-C5aR) MoAb, S5/1, HE COMPLEMENT SYSTEM is a major element of the humoral defense reaction. One group of highly active mediators that are generated by complement activation are the anaphylatoxins C3a, C4a, and C5a.' These peptides play a major role in the pathogenesis of pulmonary dysfunction, more specifically of the adult respiratory distress syndrome (ARDS).2 Elevated levels of C3a are associated with the early state of ARDS.' Moreover, anaphylatoxins trigger aggregation and activation of human polymorphonuclear neutrophilic leukocytes (PMN) in the lung resulting in a considerable damage to the lung p a r e n~h y m a .~.~ Furthermore, there is experimental evidence that lung injury caused by complement activation is related to damage of endothelial cells caused by the generation of reactive oxygen species (ROS) from PMN.' In the same study, intravenous injection of superoxide dismutase or catalase significantly protects the pulmonary damage.5 Accumulation of serum or tissue C3a was also found in several other inflammatory diseases such as chronic polyathritis,6 inflammatory arthropathies,' bullous dermatoses and
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In addition, fluid samples from biopsy specimens taken from perilesional skin from patients totally inhibited the C5a-induced production of ROS, whereas the C3a response in the presence of the anti-C5aR MoAb was unaffected. The specificity of the response was further confirmed by homologous desensitization after restimulation with C3a. In contrast, no cross-desensitization was observed upon stimulation with C5a. The C3a-induced ROS production by PMN was inhibited by pertussis toxin, indicating the involvement of guanine nucleotide-binding proteins (Gi proteins) in the signal transduction process initiated by C3a. In addition, stimulation of PMN by C3a resulted in a transient increase in the cytosolic free calcium concentration ([Ca2'li) in a dose-dependent manner. In contrast t o C3a-induced ROS production, C3a did not induce a chemotactic response in PMN, indicating functional qualitative differences as compared with C5a. In summary, these results show that C3a is a potent activator of the respiratory burst in human PMN. Therefore, these findings point t o a novel role of C3a in the pathogenesis of inflammatory diseases associated with increased C3a levels and PMN activation. with bullous dermatoses and psoriasis provoked an enhanced respiratory burst of PMN and eosinophils.' C3a and C5a were shown to bind to specific cellular receptors, thereby triggering specific cellular responses.'."'.'' Accordingly, a well-known function of C3a is the induction of smooth muscle contraction, the release of histamine from mast cells and the activation of guinea-pig platelets.' However, in contrast to its chemical analogues C5dC5a-desArg, the role of C3a in the modulation of leukocyte functions is poorly understood and controversially discussed. Earlier studies showed that C3a induced granule release, chemotaxis, and aggregation of ne~trophi1s.l~"~ However, most of the effects reported earlier have been hampered because of the contamination of C3a preparations with C5a.' More recent studies with highly purified C3a showed the existence of C3a receptors on human PMNs,'',16 interleukin-3-treated human basophils," and tumor-derived basophils.18 In addition, it had been shown that C3a induces a transient rise in the cytosolic calcium concentration ([Ca"],) in human To evaluate the potential role of C3a in PMN activation, its effect on the respiratory burst as a measure of the microbicidal and tissue destructive power of PMN was determined. Moreover, possible postreceptor events that are involved in the activation of the respiratory burst were investigated.
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MATERIALS AND METHODS
Preparation of C3a, C3a-desArg, and C5a. The C3a fragment was purified from human serum that was activated at 37°C for I hour by 10 mglmL zymosan (Serva, Heidelberg, Germany) in the presence of 1 mmol/L DL-2-mercaptomethyl-3-guanidinoethylthiopropanoic acid (Calbiochem Novachem, San Diego, CA). After 10% polyethylene glycol (PEG 6000; Serva) precipitation at pH 4.0, the supernatant was applied to K17R-sepharose at pH 7.4. K1712 is a MoAb with specificity for C3dC3a-desArg. Highly purified C3a was eluted from the immunoaffinity resin by 0.1 mol/L citrate, pH 3.5. C3a was finally purified and concentrated by cation-exchange 
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chromatography on Mono-S (Pharmacia, Freiburg, Germany) using a linear gradient from 0 to 0.5 mol/L NaCl in 50 mmol/L phosphate, pH 7.0. The purity of the C3a preparation was ascertained by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and silver protein staining. The contamination by C5a was below the detection limit of a sensitive enzyme-linked immunosorbent assay,'' ie, 0.0001%. Endotoxin concentration of the C3a preparation was under the detection limits of the Limulus amoebocyte lysate assay (Sigma Chemicals, Deisenhofen, Germany). C3a was converted into the desArg form by incubation (1 hour at 37°C) with porcine carboxypeptidase B (Boehringer, Mannheim, Germany) (1O:l wt:wt). To exclude the possibility that carboxypeptidase B has an effect on the biologic activities, FMLP (Sigma) was preincubated with carboxypetidase B in the same way as described for C3a-desArg. Recombinant human C5a was purchased from Sigma (Sigma Chemicals) and C5a-desArg was prepared as described for C3a-desArg.
Monoclonal antibodies (MoAbs) with specijicity for C3a and the C5a receptor. The MoAb K13/16 (isotyp IgGlk) recognizes an epitope that is present on human C3, C3a, and C3a-desArg. This MoAb blocks C3a biologic activity in a guinea-pig platelet activation assay." The anti-C5a receptor MoAb (anti-C5aR MoAb S5/1; isotype IgG2a/k) recognizes an epitope (Aspl5-Asp21) on the NH2-terminal domain of the C5a receptor." This MoAb interferes with ligand binding to its receptor and thereby antagonizes C5a/C5a-desArg biologic activity."
Isolation of human PMN. Human granulocytes were isolated from heparin-anticoagulated venous blood from normal nonatopic healthy donors using Ficoll-Hypaque (Pharmacia) density gradient centrifugation as described previously.** Purified PMN (96% neutrophilic PMN; 4% eosinophils) were resuspended in HEPES-buffered Hanks' Balanced Salt Solution (HBSS; GIBCO, Grand Island, NY), pH 7.4 containing 1 mg/mL bovine serum albumin (HBSSIBSA).
Lucigenin-dependent chemiluminescence (CL). CL represents a sensitive method to measure the extracellular release of ROS,23,24 which is mainly dependent on the release of superoxide anion because more than 80% of the signal is inhibited by superoxide dismutase." Lucigenin-dependent CL was measured using a single-photon imaging system with a two-dimensional photon counting system (MTP reader; Hamamatsu Photonics, Herrsching, Germany) as described e l s e~h e r e .~~.~~ This system allows to measure and analyze kinetic responses of 96 wells simultaneously. In brief, PMN were suspended to a density of 5 X lo5 cells/mL in HBSSBSA, respectively, containing 200 pmollL lucigenin (Sigma). Aliquots (100 pL) containing 5 X lo4 PMN were placed into flat-bottom white microtiter plates (Microfluor; Dynatech, Denkendorf, Germany). Measurements were performed in triplicate at 37°C. Integral counts from 0 to 60 minutes incubation interval after addition of the stimuli to the cell sample were measured and expressed as intensity integral counts.
Hydrogen peroxide ( H 2 0 z ) assay. The intracellular production of hydrogen peroxide (H,O,) was measured with dihydrorhodamine 123 (DHR; Molecular Probes, Eugene, OR), as described previously in Briefly, the nonfluorescent DHR is oxidized by H202 during the respiratory burst to brightly fluorescent rhodamine 123. Human PMN (2.5 X I05/mL) were labeled with 1 pmoW DHR and preincubated for 5 minutes at 37°C. Thereafter, cells were stimulated either with C3a, C5a, or medium and incubated for 25 minutes at 37°C. At the end of this second incubation period, cells were routinely stained with an anti-CD16 phycoerythrin (PE)-labeled MoAb (3G8-PE, isotype IgGl; Dianova, Hamburg, Germany). Therefore, simultaneous measurement of H20z (emission at 525 nm, green fluorescence, FL 1) and surface marker expression of CD16 (emission at 585 nm, red fluorescence, FL 2) was performed to distinguish between CD 16' PMN and CD 16-eosinophils as the source of H20z generation.
Toxin treatment of PMN. Bordetella pertussis toxin (Calbiochem Novabiochem, San Diego, CA) treatment was performed by incubation of 1 X 10' cells/mL for 120 minutes at 37°C with and without 2 pg/mL pertussis toxin as described el~ewhere.'~ The cells were then washed and resuspended in test medium.
Measurement of [Ca"], in human PMN. Flow cytometric analysis was used to resolve changes in single cell [CaztIi distribution by simultaneously staining with an anti-CD16 antibody to distinguish between CD16' PMN and CD16-The loading procedure of PMN with fluo-3 acetoxymethyl ester (Molecular Probes) and flow cytometrical analysis was performed as described previously.32 The samples were excited by an argon laser at 488 nm and emission was measured at 530 nm using the logarithmic (log) mode where an increase in fluorescence reflects an increase in [Ca2+]i.3n Events were continuously acquired using "Chronys" software (Becton Dickinson) that converted the log fluorescence intensity means into a linear mean fluorescence channel number.32
Chemotaxis assay. Chemotactic activity of PMN was performed as described previously using the modified Boyden chamber technique. 33 Briefly, Boyden chambers (Nuclepore GmbH, Tubingen, Germany) were filled with different concentrations of the stimuli and covered with polycarbonate filters (pore size, 3 pm; Nuclepore). One hundred microliters of a human PMN suspension at a concentration of 5 X 10S/mL was added to each chamber. After incubation for 1 hour at 37°C migrated cells in the lower part of the Boyden chambers were lysed by adding 0.1 ' % Triton X-100, and P-glucuronidase activity in the lysates was determined photometrically using p-nitrophenyl P-D-glucuronide as a substrate (all by Sigma). For calculation of the number of migrated cells, equivalent to P-glucuronidase activity determined in the lower part of the Boyden chamber, values were calculated by a computer-assisted technique from a standard curve using known numbers of unchallenged PMN. Chemotactic activity was expressed as chemotactic index: quotient of the number of migrating cells in presence of stimuluslmigrating cells in presence of medium.
Statistical analysis. Unless otherwise stated, the data in the text and figures were expressed as mean t SEM. Analysis of variance (ANOVA) was used for comparing experimental group to control value. If global test for differences was significant at the 5% level, pair wise tests for differences between groups were applied (Student's t-test for paired data using 5% significance level, closed test procedure).
RESULTS
C3a, but not C3a-desArg, induces the respiratory burst in PMN. The effect of highly purified C3a on the activation of the respiratory burst in human PMN was investigated using lucigenin-dependent CL. As shown in Figs 1 and 2, C3a significantly induced a dose-dependent production of ROS in human PMN in the range of 10 and 1000 ng/mL. Half-maximal and maximal reactive oxygen production were found at S0 ng/mL and 1000 ng/mL C3a, respectively (Fig   2) . The response upon stimulation with C3a was rapid, reaching maximum values within 2 minutes at 37°C (Fig l) , and was similar to the reaction of cells which were exposed to C5a. As compared with C3a, C5a was more active (Fig 2) . In contrast to C3a, C3a-desArg (100 to 1,000 ng/mL) did not activate the respiratory burst in PMN (Fig 2) . However, although the response was not as pronounced as the signal obtained with CSa (Fig 2) , CSa-desArg significantly induced the production of ROS (100 to 1,000 ng/mL) in PMN (Fig  2) . To exclude the possibility that carboxypeptidase B by itself has an effect on the biologic activities, FMLP was Flow cytometry shows that C3a activates the respiratoq burst in CD16' PMN. To rule out the possibility that the C3a-induced activation of the respiratory burst in neutro- philic granulocytes is caused by contaminating other cell types, particularly eosinophils, H202 was measured in CD16' cells using flow cytometry. Stimulation of anti-CD16-stained cells with C3a resulted in a significant fluorescence increase indicating the production of H202 (Figs 3  and 4) . However, C5a was much more active (Fig 3) . Dotplot analysis of anti-CD16-stained cells showed that predominantly CD16' cells (97% 5 3%; mean t SD). ie,
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. . neutrophilic PMN, were responsible for the fluorescence increase induced by C3a or CSa, respectively (Fig 3) . However, the smaller CD16-cell population, ie, eosinophils, were also activated by C3a and CSa, respectively.
Specificio of C3a-induced activation of the respiraton burst. To rule out the possibility that the effects of C3a are caused by contamination by CSa, the specificity of the C3a-induced activation of the respiratory burst was investigated using MoAbs with specificity for the CSa receptor or 3321 C3a. Preincubation of PMN with 11 &mL of the anti-CSa receptor MoAb, SS/I (anti-CSaR). which blocks a binding site of the CSa receptor." totally abolished the CSa-induced production of ROS (Fig S) . In contrast, the C3a-induced production of ROS of anti-CSaR MoAb-treated PMN was unaffected (Fig S) . Furthermore, preincubation of C3a with a threefold molar excess of Fab fragments of a MoAb (antiC3a), which neutralizes C3a activity in a guinea-pig platelet adenosine triphosphate (ATP)-release assay.20 totally abolished the C3a-induced production of ROS in PMN (Fig S) . In contrast. anti-C3a MoAb did not diminish the production of ROS when PMN were stimulated with CSa (data not shown).
C3a-ind~rced ccctivation of the respirrrton h r s t undergoes homologolrs desensitization. but not cross-de.serlsiti,atir,n to C5a. To further examine the specificity of the anaphylatoxin-induced activation of PMN, desensitization experiments were performed using C3a and CSa as the agonists. To this end PMN were prestimulated with C3a. CSa. or medium, respectively (Fig 6A) . After 1 hour the cells were restimulated with the same agents. Whereas C3a-prestimulated cells were not activated by restimulation with C3a. CSa was able to induce the production of ROS in these cells (Fig 6B) . In addition. CSa-prestimulated PMN showed a production of ROS only after restimulation with C3a. but not with CSa (Fig 6B) . Stimulation of PMN by phorbol myristate acetate (PMA). a receptor-independent agonist. as a third stimulus resulted in an additional ROS production (data not shown). Therefore. desensitization of C3a or CSa was not caused by a lack of recovery of the cells to produce additional ROS.
C3a-induced actisation of the respiraton burst is pertus-
s i s toxin sensitive. To get more insight into the postreceptor events after C3a stimulation, possible inhibitory effects of pertussis toxin were investigated using lucigenin-dependent chemiluminescence. Pretreatment of PMN with pertussis
Medium C3a
C5a PMA   Fig 4. C3a induces the production of H202 in human PMN. H202 production of PMN after stimulation with medium, C3a (500 nglmL), C5a (100 ng/mL) and PMA (10 ng/mL). Data are shown as mean log fluorescence channel number t SEM; global differences between groups: P c .001 (ANOVA); * P c .001 compared with medium stimulated cells (Student's t-test).
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Medium
C3a S00 ng/ml A n t i -C h + C3a 500 ng/ml toxin, which adenosine diphosphate (ADP)-ribolysates Gi protein^,'^ inhibited the C3a-induced production of ROS (Table l). The C5a-induced ROS production was also totally inhibited in the presence of pertussis toxin (Table l) . In contrast to C3a and C5a, the PMA-induced activation of the respiratory burst after pertussis toxin treatment was only slightly reduced ( Table 1) .
Changes of [Ca"], in PMN in response to C3a. Besides the involvement of Gi proteins in the C3a-mediated activation of the respiratory burst, changes in [Ca2'], play an important role as a second messenger.34 Therefore, flow cytometric analysis was used to resolve changes in single cell [Ca2+Ii distribution by simultaneously staining with an anti-CD16 antibody to distinguish between CD16' PMN and CD16-eosinophil^.^' C3a induced a rapid dose-dependent increase in [Ca"], in PMN reaching maximum levels 10 seconds after stimulation (Fig  7) . C3a led to increases of arbitrary fluorescence units from 236 ? 10 (medium) to 432 ? 20 (C3a 1000 ng/mL; P 5 .001 v medium) and 350 t 25 (C3a 100 ng/mL; P 5 ,001 v medium). This [Ca2'Ii increase was transient and decreased within 60 seconds to basal levels of unstimulated cells (Fig 7) . Whereas C3a-ELSNER ET AL induced [Caz'Ii increase in PMN returned to the basal level within 60 seconds, the C5a-induced [Ca*'], increase (maximum 436 t 30 arbitrary fluorescence units; P s ,001 v medium) was still elevated (Fig 7, below) and returned to the basal level within 160 seconds (data not shown).
C3a does not induce chemotaxis of PMN. Because [Ca"], transients and G-proteins are also involved in the signal transduction of P M N c h e m o t a x i~,~~ the modified Boyden chamber technique was performed to investigate the chemotactic activity of C3a. C3a did not induce a significant chemotactic response in human PMN in the range between 1 and 1,000 ng/mL (chemotactic index: 1.08 t 0.1). In contrast, C5a dose-dependently (at 1 ng/mL: 4.2 ? 0.4; at 10 ng/mL: 4.4 2 0.5; at 100 ng/mL: 2.7 2 0.2) induced a chemotactic response in PMN.
DISCUSSION
Increased serum levels of C3a are suggested to reflect complement activation in a variety of inflammatory diseases, particularly in ARDS.2-5 Recently, it was shown that lung damage was dependent on complement activation as well as the generation of ROS by PMN.5 However, the pathophysiologic role of C3a in the activation of effector cells, such as PMN, during inflammation could not be determined.' To get more insight in the potential role of human C3a in inflammation, its effect on the release of ROS by PMN was investigated.
C3a significantly induced the production of ROS in human PMN in a concentration-dependent manner, whereas C3a-desArg was inactive. Under physiologic conditions the carboxypeptidase-N rapidly removes the C-terminal arginine of C5a and C3a that is essential for most of their biologic activities.3s The inability of C3a-desArg to stimulate PMN is in accordance with previous findings that removal of the arginine residue leads to a complete abrogation of C3a binding's and biologic activity." The C5a-desArg-induced activation of the respiratory burst in PMN is also in accordance with reports on the biologic activity of C5a-desArg, although CSa-desArg is a weaker stimulus than C5a.'4.36 However, our results are in contrast to previous studies that C3a is not able to stimulate effector functions of PMN.','',l7 A possible explanation of these conflicting results might be the comparatively higher sensitivity of detection of ROS by lucigenindependent chemiluminescence than by superoxide-dismutase inhibitable reduction of cytochrome C that had been shown in several s t~d i e s .~* .~~ On the other hand, it is tempting to speculate that C3a-mediated activation of the respiratory burst is only possible if serum carboxypeptidase-N is completely blocked during the preparation of C3a.
To rule out that C3a-induced ROS production is caused by contaminating eosinophils in the cell preparations, simultaneous measurement of H202 and antibody staining was performed using flow cytometry. This approach showed that C3a-induced production of H202 by CD16-positive PMN is not caused by contaminating eosinophils, although the latter are also able to produce ROS in response to C3a and Thus, the activation of the respiratory burst in response to C3a could be confirmed by using an additional sensitive method. The specificity of the C3a-induced activation of the respiratory burst was investigated using MoAbs against the antiC5aR and C3a (anti-C3a). Blockade of specific functionally important surface receptors by MoAbs often lead to a loss or abolition of the stimulus-induced cell response. Recently, anti-C5aR antibodies were found to effectively block C5a-mediated PMN enzyme release and [Ca2+Ii transients." In the present study, it was shown that the anti-CSaR MoAb S5/1 blocked the production of ROS upon stimulation with C5a, but not with C3a, thereby providing evidence that the anti-C5aR MoAb recognizes a functionally important epitope of the C5a receptor on PMN. Therefore, the C3a-induced production of ROS in the presence of anti-C5aR MoAb could not be explained by a contamination of purified C3a with traces of C5a. Furthermore, the C3a-induced production of ROS could be antagonized by Fab fragments of a C3a-specific MoAb that had been shown to neutralize C3a activity in a guinea-pig platelet ATP-release assay."
Homologous desensitization of C3a, but failure to crossdesensitize upon stimulation with C5a further confirmed the Cells were preincubated with pertussis toxin or medium for 2 hours as described in Materials and Methods. Thereafter, PMN were stimulated either with medium, C3a, C5a, or PMA. Data are expressed as the mean of integral intensity counts (XlO-') -c SEM using lucigeninspecificity of C3a-induced PMN activation. These data are also in accord with previous reports showing homologous desensitization of C3a-induced [Ca2+Ii changes in human PMNL6 and in tumor-derived basophils." Although crossdesensitization experiments are only a preliminary and indirect way of showing the specificity of novel ligand-receptor interactions, previous studies in leukocytes with C3dC5a have shown the predictive value of this experimental approach."
Stimulation of PMN by chemoattractants such as C5a involves pertussis-toxin-sensitive Gi proteins followed by an activation of phospholipase C.38 The latter enzyme cleaves phosphatidylinositol 4,5-bisphosphate into the intracellular messengers inositol 1,4,5-trisphosphate (IP,) and 1,2-sn-diacylglycerol (DAG)." Soluble IP3 causes the release of sequestered Ca2' into the cytosol, which in combination with DAG, results in the activation of protein kinase C." Protein kinase C has been implicated in many biologic regulatory mechanisms, including the activation of the NADPH oxidase.34,3x Herein, we could show that pertussis toxin, which ADP-ribosylates Gi proteins, inhibited the C3a-induced production of ROS. Therefore, C3a-induced activation of the respiratory burst in PMN is mediated via pertussis-toxinsensitive Gi proteins. These data are in agreement with previous findings that C3a stimulates [Ca2+Ii transients in a pertussis-toxin-sensitive manner in PMN.I6
The smaller and shorter [Ca"], signal in PMN after stimulation with a maximal dose of C3a, compared with that induced by a maximal dose of C5a, is consistent with findings described previously.'6 Therefore, besides the involvement of Gi proteins, [Ca2'Ii transients are also involved in the signal transduction process upon stimulation with C3a.
Because [Ca"Ii transients and Gi proteins are also involved in the signal transduction of PMN c h e m o t a x i~,~~ the effect of C3a on the chemotactic activity of PMN was investigated. In contrast to C5a, C3a did not induce a chemotactic response of human PMN. These data are in agreement with previous studies showing that C3a does not stimulate chemotaxis in PMN.' Moreover, these data clearly show that PMN activation upon stimulation with C5a and C3a differed in the quality of the cell response.
In summary, this study showed biologic effects of C3a in the activation of human PMN. C3a-induced activation of the respiratory burst was shown to be dependent on binding to specific C3a receptors, which are different from C5a receptors. Stimulation of PMN by C3a stimulation involved pertussis toxin-sensitive Gi proteins and led to a transient rise in the [Ca2+], . In contrast to C5a, C3a did not induce chemotaxis in PMN. Therefore, these findings point to a novel role of C3a in the pathogenesis of inflammatory diseases associated with increased C3a levels and PMN activation, particularly in ARDS.
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